Edition:
United States

People: Acura Pharmaceuticals Inc (ACUR.O)

ACUR.O on Consolidated Issue listed on NASDAQ Capital Market

1.94USD
29 Jul 2016
Change (% chg)

$0.03 (+1.67%)
Prev Close
$1.91
Open
$1.90
Day's High
$1.95
Day's Low
$1.80
Volume
7,333
Avg. Vol
37,157
52-wk High
$4.15
52-wk Low
$1.61

Jones, Robert 

Mr. Robert B. Jones is President and Chief Executive Officer, Director of the company. He has been our President and Chief Executive Officer since July 7, 2011. From April 2011 through July 6, 2011, Mr. Jones was our Interim President and Chief Executive Officer. Mr. Jones was our Senior Vice President and Chief Operating Officer from April 2008 to April 2011. From May, 2003 to March, 2008, Mr. Jones served first as the Vice President, Finance and then as Vice President, Strategy and Business Analysis of Adolor Corporation. From November 2000 to May 2003 he served as Vice President, Finance and then as Chief Operating Officer of Opt-E-Script, Inc., a privately held personalized medicine company where Mr. Jones was responsible for all commercialization activities. Prior to that, Mr. Jones was Vice President, Sales and Marketing for Purepac Pharmaceutical Company. Mr. Jones received his M.B.A. from the University of North Carolina and a B.S. from Cornell University. Mr. Jones was appointed a director of the Company in July 2011.

Basic Compensation

Total Annual Compensation, USD 387,000
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 116,424
Fiscal Year Total, USD 503,424

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Robert Jones

503,424

Peter Clemens

363,160

Robert Seiser

196,948

J. Bradley Rivet

209,422

Albert Brzeczko

351,528

James Emigh

196,948
As Of  30 Dec 2014